Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Praxis Precision Medicines, Inc.PRAX · Entity 3538 | Director | June 10, 2026 | June 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Praxis Precision Medicines, Inc.
Report date June 10, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,371 |
Reported balance
After 2026-06-10 transaction · row 1
1 source rowRow 1 · 2026-06-10 · Grant · Acquired 1,371 · Balance 1,371 F1: Dr. Cudkowicz was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $240.66 · Expires 2036-06-10 | Direct | 648 |
Reported balance
After 2026-06-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-10 · Grant · Acquired 648 · Balance 648 F2: The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Dr. Cudkowicz was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
F2: The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2026 Filed Jun 12, 2026 21:24 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 648 | $0.00 Strike: $240.66 | $0.00 |
DisclosureSEC source: 0001689548-26-000060 · wk-form4_1781299441.xml · derivative · entry 2 Cudkowicz Merit Ester · CIK 0001856299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 648 Underlying: Common Stock · 648 shares Expires 2036-06-10 F2 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 21:24 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 1,371 | $0.00 | $0.00 |
DisclosureSEC source: 0001689548-26-000060 · wk-form4_1781299441.xml · nonDerivative · entry 1 Cudkowicz Merit Ester · CIK 0001856299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,371 F1 · kind: Dr. Cudkowicz was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| June 26, 2025 Filed Jun 27, 2025 20:54 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 10,520 | $0.00 Strike: $44.04 | $0.00 |
DisclosureSEC source: 0001689548-25-000076 · wk-form4_1751057675.xml · derivative · entry 1 Cudkowicz Merit Ester · CIK 0001856299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,520 Underlying: Common Stock · 10,520 shares Expires 2035-06-26 F1 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on June 26, 2025. Read SEC document |
| June 05, 2024 Filed Jun 6, 2024 22:55 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 8,566 | $0.00 Strike: $44.25 | $0.00 |
DisclosureSEC source: 0001689548-24-000076 · wk-form4_1717714540.xml · derivative · entry 1 Cudkowicz Merit Ester · CIK 0001856299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,566 Underlying: Common Stock · 8,566 shares Expires 2034-06-05 F1 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on June 5, 2024. Read SEC document |
| June 12, 2023 Filed Jun 14, 2023 11:13 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 28,981 | $0.00 Strike: $0.96 | $0.00 |
DisclosureSEC source: 0001689548-23-000108 · wf-form4_168674118038925.xml · derivative · entry 1 Cudkowicz Merit Ester · CIK 0001856299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,981 Underlying: Common Stock · 28,981 shares Expires 2033-06-12 F1 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on June 12, 2023. Read SEC document |
| May 26, 2022 Filed May 27, 2022 21:26 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 22,753 | $0.00 Strike: $8.38 | $0.00 |
DisclosureSEC source: 0001689548-22-000065 · wf-form4_165368673756016.xml · derivative · entry 1 Cudkowicz Merit Ester · CIK 0001856299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,753 Underlying: Common Stock · 22,753 shares Expires 2032-05-26 F1 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on May 26, 2022. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 20:30 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 38,579 | $0.00 Strike: $31.65 | $0.00 |
DisclosureSEC source: 0001689548-21-000033 · wf-form4_161981459998804.xml · derivative · entry 1 Cudkowicz Merit Ester · CIK 0001856299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,579 Underlying: Common Stock · 38,579 shares Expires 2031-04-28 F1 · derivative.exercise_date: The shares subject to this option shall vest in thirty-six (36) equal monthly installments over three (3) years commencing on April 28, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.